Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4577882 | 0.81 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEPRNPEP | |
| SCHEMBL11890301 | 0.80 | — | — | |
| SCHEMBL107498 | 0.80 | — | — | |
| SCHEMBL11890306 | 0.80 | — | — | |
| SCHEMBL108359 | 0.79 | TSHR (0.50) | TSHRALDH1A1MAPK1ANPEPRNPEP | |
| SCHEMBL7165294 | 0.75 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEPRNPEP | |
| SCHEMBL25907639 | 0.75 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEPRNPEP | |
| SCHEMBL105046 | 0.75 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEPRNPEP | |
| SCHEMBL25907640 | 0.75 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEPRNPEP | |
| SCHEMBL13742376 | 0.75 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106573886-B | Method for producing cyclic alpha-ketols from cyclic alpha-ketoenols | 巴斯夫欧洲公司 | 2020-10-30 | — | — | CN | disclosed |
| EP-3180311-B1 | METHOD FOR PRODUCING ASTAXANTHIN FROM ASTACIN | BASF SE (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-10017464-B2 | Process for preparing cyclic alpha-keto alcohols from cyclic alpha-keto enols | BASF SE (DE) | 2018-07-10 | — | — | US | disclosed |
| US-10017465-B2 | Method for producing astaxanthin from astacin | BASF SE (DE) | 2018-07-10 | — | — | US | disclosed |
| US-20170233338-A1 | METHOD FOR PRODUCING ASTAXANTHIN FROM ASTACIN | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| US-20170217884-A1 | PROCESS FOR PREPARING CYCLIC ALPHA-KETO ALCOHOLS FROM CYCLIC ALPHA-KETO ENOLS | BASF SE (DE) | 2017-08-03 | — | — | US | disclosed |
| EP-3180311-A1 | METHOD FOR PRODUCING ASTAXANTHIN FROM ASTACIN | BASF SE (DE) | 2017-06-21 | — | — | EP | disclosed |
| EP-3180310-A1 | PROCESS FOR PREPARING CYCLIC ALPHA-KETO ALCOHOLS FROM CYCLIC ALPHA-KETO ENOLS | BASF SE (DE) | 2017-06-21 | — | — | EP | disclosed |
| WO-2016023772-A1 | PROCESS FOR PREPARING CYCLIC ALPHA-KETO ALCOHOLS FROM CYCLIC ALPHA-KETO ENOLS | BASF SE (DE) | 2016-02-18 | — | — | WO | disclosed |
| WO-2016023732-A1 | METHOD FOR PRODUCING ASTAXANTHIN FROM ASTACIN | BASF SE (DE) | 2016-02-18 | — | — | WO | disclosed |
| WO-2015159033-A1 | PROCESS FOR PREPARING NATURAL MINERAL ACIDS, AND USE OF THE OBTAINED ACIDS IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-10-22 | — | — | WO | disclosed |
| WO-2014012054-A1 | ALZHEIMER'S DISEASE ASSAY IN A LIVING PATENT | PAIN THERAPEUTICS, INC. (US) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233338-A1 | METHOD FOR PRODUCING ASTAXANTHIN FROM ASTACIN | ADH1B, ADH5, ADH7 | TSHR 3210/4885ALDH1A1 179/4885MAPK1 4698/4885 |
| US-10017465-B2 | Method for producing astaxanthin from astacin | ADH1B, ADH5, ADH7 | TSHR 3210/4885ALDH1A1 179/4885MAPK1 4698/4885 |
| US-20170217884-A1 | PROCESS FOR PREPARING CYCLIC ALPHA-KETO ALCOHOLS FROM CYCLIC ALPHA-KETO ENOLS | AKR1C3, AKR1C2, AKR1A1 | TSHR 3170/4885ALDH1A1 198/4885MAPK1 4189/4885 |
| US-10017464-B2 | Process for preparing cyclic alpha-keto alcohols from cyclic alpha-keto enols | AKR1C3, AKR1C2, AKR1A1 | TSHR 3170/4885ALDH1A1 198/4885MAPK1 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.